Chromosomal instability in patients with Fanconi anemia from Serbia

Sanja Ćirković; Marija Guć-Šćekić; Dragana Vujić; Dragan Mićić; Dejan Škorić

doi:10.2298/1591

Sanja Ćirković Department of Medical Genetics, Mother and Child Health Care Institute of Serbia “Dr Vukan Čupić”, Belgrade, Serbia
Marija Guć-Šćekić Department of Medical Genetics, Mother and Child Health Care Institute of Serbia “Dr Vukan Čupić”, Belgrade, Serbia; Faculty of Biology, University of Belgrade, Belgrade, Serbia
Dragana Vujić Department of Bone Marrow Transplantation with Laboratory for Cryobiology, Mother and Child Health Care Institute of Serbia “Dr Vukan Čupić”, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Dragan Mićić Department of Hematology – Oncology, Mother and Child Health Care Institute of Serbia “Dr Vukan Čupić”, Belgrade, Serbia
Dejan Škorić Department of Hematology – Oncology, University Children’s Hospital, Faculty of Medicine, University of Belgrade, Belgrade, Serbia

DOI: https://doi.org/10.2298/1591

Keywords: fanconi anemia, diagnosis, differential, cytogenetics, chromosome aberrations, chromosome disorders,

Abstract

Background/Aim. Fanconi anemia (FA) is a rare hereditary disease in a heterogeneous group of syndromes, so-called chromosome breakage disorders. Specific hypersensitivity of its cells to chemical agents, such as diepoxybutane (DEB), was used as a part of screening among patients with clinical suspicion of FA. The aim of this study was to determine chromosomal instability in patients with FA symptoms in Serbia. Methods. A total of 70 patients with phenotypic symptoms of FA, diagnosed at the Mother and Child Health Care Institute of Serbia “Dr Vukan Čupić”, Belgrade and University Children’s Hospital, Belgrade from February 2004 to September 2011, were included in this study. Cytogenetic instability analysis was performed on untreated and DEB-treated 72 h-cultures of peripheral blood. Results. Ten patients in the group of 70 suspected of FA, showed increased DEB induced chromosome breakage and were classified into the FA group. The range of DEB induced aberrant cells percentages in the FA group was from 32% to 82%. DEB sensitivity of 58 tested patients were bellow FA values (range: 0–6%) (non-FA group), with no overlapping. The remaining two patients showed borderline sensitivity (borderline FA group – FA*), comparing to the healthy controls. Conclusion. This study revealed 10 patients with FA on the basis of cytogenetic analysis of DEB induced chromosome aberrations. Our results are in consistency with those from the literature. Early and precise diagnosis of FA is very important in further treatment of these patients, considering its cancer prone and lethal effects.

References

Hisama FM, Tekumalla PK., Weissman SM. Overview of Chromosomal Instability and Aging Mechanisms. In: Hisama FM, Poornima K. Tekumalla, Weissman SM, Martin GM, editor. Chromosomal Instability and Aging: Basic Science and Clinical Implications. New York, Basel: Marcel Dekker, Inc.; 2003. p. 23−41.

Wegner RD, Stumm M. Diagnosis of Chromosomal Instability Syndromes. In: Wegner RD, editor. Diagnostic cytogenetics. Berlin: Springer-Verlag 1999. p. 251−68.

Auerbach AD. Diagnosis of Fanconi Anemia by Diepoxybu-tane Analysis. In Dracopoli NC, Haines JL, Korf BR, Morton CC, Seidman CE, Rosenzweig A, et al, editors. Short Protocols in Human Genetics. New Jersey: John Wiley and Sons, 2004. p. 31−7.

Alter BP. Inherited bone marrow failure syndromes. In: Handin RI, Stossel TP, Lux SE, editors. Blood: Principles and Practice of Hematology. Philadelphia: JB Lippincott 1995. p. 227−91.

Bagby GC, Lipton JM, Sloand EM, Schiffer CA. Marrow failure. Hematology Am Soc Hematol Educ Program 2004; 318−36.

Shaffer LG, Tommerup NS. ISCN 2009. An International System for Cytogenetic Nomenclature. Basel: Karger; 2009.

Huret JL. Fanconi anaemia. Atlas Genet Cytogenet Oncol Haematol 1998; 2(2): 68−9.

Alter BP. Fanconi’s anemia and malignancies. Am J Hematol 1996; 53(2): 99−110.

Dokal I, Vulliamy T. Inherited bone marrow failure syndromes. Haematologica 2010; 95(8): 1236−40.

Esmer C, Sanchez S, Ramos S, Molina B, Frias S, Carnavale A. DEB test for Fanconi anemia detection in patients with atypical phenotypes. Am J Med Genet A 2004; 124A(1): 35−9.

Liu JM, Buchwald M, Walsh CE, Young NS. Fanconi anemia and novel strategies for therapy. Blood 1994; 12(84): 3995−4007.

Kook H, Cho D, Cho SH, Hong WP, Kim CJ, Park JY, et al. Fan-coni anemia screening by diepoxybutane and mitomicin C tests in Korean children with bone marrow failure syndromes. J Korean Med Sci 1998; (6): 623−8.

Auerbach AD, Rogatko A, Schroeder-Kurth TM. International fan-coni anemia registry: relation of clinical symptoms to diepox-ybutane sensitivity. Blood 1989; 73(2): 391−6.

Ilgin H, Akarsu AN, Bokesoy FI. Cytogenetic and phenotypic findings in Turkish patients with Fanconi anemia. Tr J Med Sci 1999; 29(2): 151−4.

Cho SH, Kook H, Kim GM, Yoon WS, Cho TH, Hwang TJ. A clinical study of Fanconi’s anemia. Korean J Pediatr Hemato-log Oncol 1997; 4(1): 70−7.

Soulier J, Leblanc T, Larghero J, Dastot H, Shimamura A, Guardiola P, et al. Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA path-way. Blood 2005; 105(3):1329−36.

Lo Ten Foe JR, Kwee ML, Rooimans MA, Oostra AB, Veerman AJ, van Weel M, et al. Somatic mosaicism in Fanconi anemia: mole-cular basis and clinical significance. Eur J Hum Genet 1997; 5(3):137−48.

Gross M, Hanenberg H, Lobitz S, Friedl R, Herterich S, Dietrich R, et al. Reverse mosaicism in Fanconi anemia: natural gene ther-apy via molecular self-correction. Cytogenet Genome Res 2002; 98(2−3):126−35.

Youssoufian H. Natural gene therapy and the Darwinian legacy. Nat Genet 1996; 13(3): 255−6.

Castella M, Pujol R, Callén E, Ramírez MJ, Casado JA, Talavera M, et al. Chromosome fragility in patients with Fanconi anaemia: diagnostic implications and clinical impact. J Med Genet 2011; 48(4): 242−50.

Alter BP, Kupfer G. Fanconi anemia. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, editors. GeneRe-views™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2013. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1401/ [updated 2013 Feb 07]